Dhar Debojyoti
Leucine Rich Bio Pvt. Ltd., Bengaluru, India.
Front Neurosci. 2022 Jan 17;15:831193. doi: 10.3389/fnins.2021.831193. eCollection 2021.
Coronavirus disease 2019 (COVID-19) is a major pandemic facing the world today caused by SARS-CoV-2 which has implications on our mental health as well. The uncertain future, fear of job loss, lockdown and negative news all around have taken a heavy toll on the mental health of individuals from across the world. Stress and anxiety can affect the COVID-19 patients even more. Recent study suggests COVID-19 infection may lead to post-traumatic stress disorder (PTSD). Certain prebiotics and probiotics have been shown to have anxiolytic effect through gut microbiota modulation. Incidentally, preliminary report also suggests a differential microbial profile in COVID-19 patients as compared to healthy individuals. Gut microbiota's role in anxiety and depression is well studied. The importance of the "gut-brain" axis has been implicated in overall mental health. It is known that diet, environmental factors and genetics play an important role in shaping gut microbiota. Trials may be initiated to study if personalized diet and supplementation based on individual's gut microbiome profile may improve the general mental well-being of people prone to anxiety during this pandemic. Also, COVID-19 patients may be provided personalized nutritional therapy based on their gut microbiota profile to see if PTSD and anxiety symptoms can be alleviated.
2019冠状病毒病(COVID-19)是当今世界面临的一场重大疫情,由严重急性呼吸综合征冠状病毒2(SARS-CoV-2)引起,它也对我们的心理健康产生影响。不确定的未来、对失业的恐惧、封锁以及到处都是的负面新闻,给世界各地人们的心理健康造成了沉重负担。压力和焦虑对COVID-19患者的影响可能更大。最近的研究表明,COVID-19感染可能导致创伤后应激障碍(PTSD)。某些益生元和益生菌已被证明可通过调节肠道微生物群产生抗焦虑作用。顺便说一句,初步报告还表明,与健康个体相比,COVID-19患者的微生物谱存在差异。肠道微生物群在焦虑和抑郁中的作用已得到充分研究。“肠-脑”轴的重要性与整体心理健康有关。众所周知,饮食、环境因素和基因在塑造肠道微生物群方面起着重要作用。可以开展试验,研究基于个体肠道微生物组特征的个性化饮食和补充剂是否可以改善在这场疫情期间易焦虑人群的总体心理健康状况。此外,可以根据COVID-19患者的肠道微生物群特征为他们提供个性化营养治疗,看看是否可以缓解创伤后应激障碍和焦虑症状。